D-Index & Metrics Best Publications
Gerhard Ehninger

Gerhard Ehninger

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 85 Citations 31,968 555 World Ranking 7572 National Ranking 349

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Gene

Gerhard Ehninger focuses on Internal medicine, Leukemia, Transplantation, Myeloid leukemia and Surgery. His biological study spans a wide range of topics, including Gastroenterology, Immunology and Oncology. His studies in Immunology integrate themes in fields like Stem cell and Graft-versus-host disease.

His Leukemia research includes themes of Myeloid, Cancer research, BAALC and NPM1. He works mostly in the field of Transplantation, limiting it down to topics relating to Placebo and, in certain cases, Clinical trial. Gerhard Ehninger has included themes like Fms-Like Tyrosine Kinase 3, Proportional hazards model, Exon, Pharmacology and Acute leukemia in his Myeloid leukemia study.

His most cited work include:

  • Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis (1384 citations)
  • Mesenchymal stem cells can be differentiated into endothelial cells in vitro. (1100 citations)
  • Retinoic acid and arsenic trioxide for acute promyelocytic leukemia (834 citations)

What are the main themes of his work throughout his whole career to date?

Gerhard Ehninger mainly investigates Internal medicine, Transplantation, Myeloid leukemia, Oncology and Immunology. His Internal medicine research incorporates elements of Gastroenterology and Surgery. His Transplantation research integrates issues from Cumulative incidence, Stem cell and Fludarabine.

His Myeloid leukemia study deals with the bigger picture of Cancer research. His Oncology study integrates concerns from other disciplines, such as Clinical trial, Proportional hazards model and Myelodysplastic syndromes. His Leukemia study typically links adjacent topics like Myeloid.

He most often published in these fields:

  • Internal medicine (51.03%)
  • Transplantation (27.44%)
  • Myeloid leukemia (23.97%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (51.03%)
  • Myeloid leukemia (23.97%)
  • Oncology (22.31%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Internal medicine, Myeloid leukemia, Oncology, Transplantation and Leukemia. His studies deal with areas such as Gastroenterology and Surgery as well as Internal medicine. His work on Midostaurin as part of general Myeloid leukemia study is frequently linked to In patient, therefore connecting diverse disciplines of science.

His Oncology research is multidisciplinary, incorporating elements of Graft-versus-host disease, European LeukemiaNet, Chemotherapy and Bioinformatics. His Transplantation study incorporates themes from Regimen, Cyclophosphamide, Immunology, Stem cell and Survival analysis. CEBPA and Myelodysplastic syndromes is closely connected to Myeloid in his research, which is encompassed under the umbrella topic of Leukemia.

Between 2015 and 2021, his most popular works were:

  • Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation (802 citations)
  • Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial (174 citations)
  • Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia (105 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Gerhard Ehninger mostly deals with Internal medicine, Leukemia, Transplantation, Myeloid leukemia and Oncology. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Surgery. His Leukemia study combines topics from a wide range of disciplines, such as Myeloid, Clinical trial, Acute promyelocytic leukemia and Cytogenetics.

His research in Transplantation intersects with topics in Cyclophosphamide, Survival analysis and Immunology, Bone marrow. His study in Myeloid leukemia is interdisciplinary in nature, drawing from both Fms-Like Tyrosine Kinase 3, Hematology, White blood cell, Proportional hazards model and NPM1. The concepts of his Oncology study are interwoven with issues in Karyotype, Midostaurin, CNS Involvement, Graft-versus-host disease and European LeukemiaNet.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

Christian Thiede;Christine Steudel;Brigitte Mohr;Markus Schaich.
Blood (2002)

1856 Citations

Mesenchymal stem cells can be differentiated into endothelial cells in vitro.

Joachim Oswald;Sabine Boxberger;Birgitte Jørgensen;Silvia Feldmann.
Stem Cells (2004)

1664 Citations

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

F. Lo-Coco;G. Avvisati;M. Vignetti;C. Thiede.
The New England Journal of Medicine (2013)

1104 Citations

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

Richard M. Stone;Sumithra J. Mandrekar;Ben L. Sanford;Kristina Laumann.
The New England Journal of Medicine (2017)

1033 Citations

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

Christian Thiede;Sina Koch;Eva Creutzig;Christine Steudel.
Blood (2006)

845 Citations

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

Claudio Anasetti;Brent R. Logan;Stephanie J. Lee;Edmund K. Waller.
The New England Journal of Medicine (2012)

708 Citations

Phase IIB trial of oral midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3

Thomas Fischer;Richard M. Stone;Daniel J. DeAngelo;Ilene Galinsky.
Journal of Clinical Oncology (2010)

553 Citations

Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

Christoph Schmid;Myriam Labopin;Arnon Nagler;Martin Bornhäuser.
Journal of Clinical Oncology (2007)

525 Citations

Cure of Helicobacter pylori Infection and Duration of Remission of Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

Andreas Neubauer;Christian Thiede;Birgit Alpen;Markus Ritter.
Journal of the National Cancer Institute (1997)

389 Citations

Safety and Cost Effectiveness of a 10 × 109/L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 109/L Trigger: A Prospective Comparative Trial in 105 Patients With Acute Myeloid Leukemia

Hannes Wandt;Markus Frank;Gerhard Ehninger;Christiane Schneider.
Blood (1998)

369 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Gerhard Ehninger

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 187

Arnon Nagler

Arnon Nagler

Sheba Medical Center

Publications: 174

Jorge E. Cortes

Jorge E. Cortes

Augusta University

Publications: 173

Mohamad Mohty

Mohamad Mohty

Université Paris Cité

Publications: 172

Martin Bornhäuser

Martin Bornhäuser

TU Dresden

Publications: 138

Myriam Labopin

Myriam Labopin

Université Paris Cité

Publications: 136

Farhad Ravandi

Farhad Ravandi

The University of Texas MD Anderson Cancer Center

Publications: 134

Xiao-Jun Huang

Xiao-Jun Huang

Peking University

Publications: 108

Richard Stone

Richard Stone

Harvard University

Publications: 105

Bipin N. Savani

Bipin N. Savani

Vanderbilt University Medical Center

Publications: 104

Christian Thiede

Christian Thiede

TU Dresden

Publications: 95

Torsten Haferlach

Torsten Haferlach

MLL Munich Leukemia Laboratory

Publications: 95

Mark J. Levis

Mark J. Levis

Johns Hopkins University

Publications: 91

Arnold Ganser

Arnold Ganser

Hannover Medical School

Publications: 91

Nicolaus Kröger

Nicolaus Kröger

Universität Hamburg

Publications: 91

Elias Jabbour

Elias Jabbour

The University of Texas MD Anderson Cancer Center

Publications: 87

Something went wrong. Please try again later.